Technescan Mag3 is a drug owned by Curium Us Llc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Nov 12, 2013. Details of Technescan Mag3's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5573748 | Radiolabeled technetium chelates for use in renal function determinations |
Nov, 2013
(10 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Technescan Mag3 is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Technescan Mag3's family patents as well as insights into ongoing legal events on those patents.
Technescan Mag3's Family Patents
Try Our Curated Drug Screens
Generic Launch
Generic Release Date:
Technescan Mag3's generic launch date based on the expiry of its last outstanding patent is estimated to be Nov 12, 2013 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Technescan Mag3 Generics:
Technetium Tc-99m Mertiatide Kit is the generic name for the brand Technescan Mag3. 2 different companies have already filed for the generic of Technescan Mag3, with Medi-radiopharma having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Technescan Mag3's generic
About Technescan Mag3
Technescan Mag3 is a drug owned by Curium Us Llc. It is used for treating erectile dysfunction. Technescan Mag3 uses Technetium Tc-99M Mertiatide Kit as an active ingredient. Technescan Mag3 was launched by Curium in 1990.
Approval Date:
Technescan Mag3 was approved by FDA for market use on 15 June, 1990.
Active Ingredient:
Technescan Mag3 uses Technetium Tc-99m Mertiatide Kit as the active ingredient. Check out other Drugs and Companies using Technetium Tc-99m Mertiatide Kit ingredient
Treatment:
Technescan Mag3 is used for treating erectile dysfunction.
Dosage:
Technescan Mag3 is available in injectable form for injection use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| N/A | INJECTABLE | Prescription | INJECTION |